Thank you for your participation.

Instructions for Registration and Completion


First-time participants should select the Register button below to complete a personal profile and create a username and password.

Returning participants, please enter your username and password and register for this activity.

Once you have registered:
To successfully complete this activity and receive your statement of credit, complete the evaluation by correctly answering 70% of the learning assessment questions. To do this, select the link on the right. A check mark will indicate when the evaluation is successfully submitted. Your certificate will be generated automatically and will appear at right in PDF format for you to print or download.





CME Information | Activity Details

   
 Dermatologic Effects of Cancer Therapy
 
 Intended Audience
This continuing education activity is designed for oncology nurses and other healthcare providers interested in the care of oncology patients. 

Learning Objectives
At the completion of this activity, participants should be better able to
    • Describe the clinical characteristics of skin rash secondary to epidermal growth factor receptor inhibitor (EGFRI)
       therapy    
    • Discuss management of hand-foot syndrome secondary to capecitabine therapy     
    • List ocular changes that may occur during treatment of oncolytic therapy    
    • Differentiate between hand-foot skin reaction and hand-foot syndrome